Treating Philadelphia chromosome/BCR-ABL1positive patients with Glivec (Imatinib mesylate): 10 years’ experience at Patan Hospital, Nepal-Reference-Cited by-同舟云学术

Treating Philadelphia chromosome/BCR-ABL1positive patients with Glivec (Imatinib mesylate): 10 years’ experience at Patan Hospital, Nepal

Published:2017-03-29 Issue:6 Volume:177 Page:991-999
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Kayastha Gyan K.¹²,Ranjitkar Nora¹²,Gurung Radha¹²,KC Raj K.¹²,Karki Sanjit¹²,Shrestha Roshan¹²,Thapa Raj K.¹²,Rajbhandari Piyush¹²,Poudyal Buddhi¹²,Acharya Paras¹²,Roberts David J.³,Hayes Bruce¹²,Zimmerman Mark¹²,Basnyat Buddha¹²⁴^ORCID,Mansfield Aaron⁵⁶

Affiliation:

1. Patan Academy of Health Science; Kathmandu Nepal

2. Patan Hospital; Kathmandu Nepal

3. National Health Service Blood and Transplant and Radcliffe Department of Medicine; John Radcliffe Hospital; Oxford UK

4. Oxford University Clinical Research Unit-Nepal; Centre for Tropical Medicine and Global Health; University of Oxford; Oxford UK

5. Division of Hematology; Department of Internal Medicine; Mayo Clinic; Rochester MN USA

6. Department of Oncology; Mayo Clinic; Rochester MN USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14645/fullpdf

Reference24 articles.

1. Clinical significance of complete cytogenetic response (CCyR) and major molecular response (MMR) achieved with different treatment modalities used as frontline therapy in chronic myeloid leukemia (CML) chronic phase (CP);Alattar;Blood (ASH Annual Meeting Abstracts),2011

2. Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet;Baccarani;Blood,2006

3. Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study;Baccarani;Blood,2009

4. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013;Baccarani;Blood,2013

5. How I treat newly diagnosed chronic phase CML;Cortes;Blood,2012

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Ten-Year Experience of Treating Chronic Myeloid Leukemia in Rural Rwanda: Outcomes and Insights for a Changing Landscape;JCO Global Oncology;2022-07

2. Meeting the needs of CML patients in resource-poor countries;Hematology;2019-12-06

3. Imatinib;Reactions Weekly;2017-08